Key Performance
More- Earnings Score: 45
- Momentum Score: 31
- True Yield: N/A
- Financial Health Score: 47
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
A class action lawsuit has been filed against Chemours Company alleging that the company failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance for 2026. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.
10/23/2026, 11:00 AM • GlobeNewswire
The Chemours Company faces a securities class action lawsuit for failing to disclose material information during February-August 2026. The company cut its full-year adjusted EBITDA guidance significantly after revealing channel oversupply issues, causing its stock to plunge 18.63% on August 5, 2026. Investors with losses exceeding $100,000 have until December 7, 2026 to file lead plaintiff applications.
10/22/2026, 2:58 PM • GlobeNewswire
A securities fraud class action lawsuit has been filed against The Chemours Company (NYSE: CC) for allegedly making materially false statements about the reliability of its financial guidance. The lawsuit covers investors who purchased CC securities between February 20, 2026 and August 4, 2026. Chemours stock fell 18.63% on August 5, 2026, after the company reduced its full-year adjusted EBITDA guidance and attributed the decline to a 4% decrease in volumes, primarily from lower Opteon refrigerant aftermarket sales. The deadline to seek lead plaintiff status is December 7, 2026.
10/20/2026, 6:10 PM • GlobeNewswire
A securities fraud class action has been filed against The Chemours Company (NYSE: CC) for allegedly overstating market demand for its Opteon products during the Class Period (February 20 - August 4, 2026). The company reduced its full-year EBITDA guidance and disclosed an oversupplied channel, causing the stock to drop 18.63% on August 5, 2026. The lead plaintiff deadline is December 7, 2026.
10/15/2026, 8:40 PM • GlobeNewswire
A securities fraud class action lawsuit has been filed against The Chemours Company (NYSE: CC) for allegedly making materially false statements about the reliability of its financial guidance. The lawsuit covers investors who purchased CC securities between February 20, 2026 and August 4, 2026. The company allegedly overstated aftermarket demand for its Opteon refrigeration products, leading to a significant stock price decline of 18.63% on August 5, 2026, after the company reduced its full-year adjusted EBITDA guidance.
10/15/2026, 5:45 PM • GlobeNewswire
ClaimsFiler reminds investors with losses exceeding $100,000 that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company. The lawsuit alleges that Chemours and its executives failed to disclose material information about channel oversupply during the Class Period (February 20 - August 4, 2026). The company cut its full-year adjusted EBITDA guidance significantly, causing its stock to fall 18.63% on August 5, 2026.
10/15/2026, 2:43 PM • GlobeNewswire
A class action lawsuit has been filed against Chemours Company alleging that the company failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.
10/15/2026, 11:00 AM • GlobeNewswire
The global high-performance fluoropolymers market is projected to grow from USD 5.17 billion in 2026 to USD 7.82 billion by 2032 at a CAGR of 7.11%, driven by semiconductor fabrication, electric vehicle electrification, battery technology, and hydrogen infrastructure demands. Key growth factors include regulatory compliance requirements, AI-driven innovation in materials discovery, and expanding applications across aerospace, medical devices, and industrial coatings.
08/27/2026, 6:56 AM • GlobeNewswire
Pomerantz LLP is investigating potential securities fraud claims against The Chemours Company following the company's August 4, 2026 announcement of reduced full-year EBITDA guidance ($775M-$825M from $800M-$900M) and management's admission of channel oversupply issues. Chemours stock fell 18.63% on August 10, 2026, following the disclosure that approximately $65 million in aftermarket sales were misallocated.
08/25/2026, 5:52 PM • GlobeNewswire
Pomerantz Law Firm has filed class action lawsuits against Blaize Holdings, Inc. and is investigating claims against Rackspace Technology and The Chemours Company. The Blaize lawsuit stems from allegations of securities fraud related to a purported deal with NeoTensr, a 4-month-old company with allegedly photoshopped product images. Following a short report by Pelican Way Research on April 28, 2026, Blaize's stock fell 12.04%. Investors have until October 5, 2026, to join the class action.
08/25/2026, 5:51 PM • GlobeNewswire
Pomerantz Law Firm has filed class action lawsuits against Planet Fitness, Rackspace Technology, and The Chemours Company, alleging securities fraud and unlawful business practices. Planet Fitness saw a significant stock price decline of 31.19% on May 7, 2026, following disappointing Q1 2026 results and reduced full-year guidance. Investors have until September 14, 2026, to join the class action.
08/25/2026, 5:47 PM • GlobeNewswire
The global glycolic acid market is projected to grow from USD 377.21 million in 2025 to USD 818.89 million by 2035, driven by increasing demand for skincare products, alpha-hydroxy acid ingredients in cosmetics, and advanced formulation technologies. The U.S. market is expected to reach USD 180.61 million and Europe USD 228.65 million by 2035, with Asia Pacific currently holding the largest market share at 39%.
08/06/2026, 6:46 AM • GlobeNewswire
Why Chemours Plunged on Wednesday
Chemours stock fell 18.7% after reporting Q2 earnings that missed revenue expectations and showed a 31% decline in adjusted EPS to $0.42. The decline was driven by lower sales of Optane refrigerants due to channel inventory buildup and the absence of the wound-down SPS Capstone business. While the company's AI-focused data center materials segment is growing, it remains too small to offset declines in larger segments. Management maintains a 1-5% full-year growth forecast, supported by price increases and R&D focus on data centers.
08/05/2026, 4:17 PM • The Motley Fool
The global blowing agent market is projected to grow from USD 1.79 billion in 2025 to USD 2.94 billion by 2035, driven by increasing demand for eco-friendly foam insulation, regulatory requirements to ban high-GWP compounds, and energy-efficient building construction. Chemical blowing agents dominate with 51.8% market share, while HFO technology is the fastest-growing segment. North America leads with 32.5% market share, with the U.S. market expected to reach USD 0.56 billion by 2035, while Europe is projected to reach USD 0.66 billion.
07/27/2026, 5:30 AM • GlobeNewswire
Why Silver, Power And Chemicals Will Be The Next Micron Trade, Top AI Expert Says
AI macro expert Jordi Visser argues the AI investment cycle is shifting from early-stage semiconductor winners like Micron to late-cycle physical bottlenecks including power generation, chemicals, and silver. He's rotating his portfolio accordingly, citing a structural mismatch between index weightings built for the software era and where economic value is actually being created in the AI buildout.
05/11/2026, 12:09 PM • Benzinga
Peers
Statistics
MoreInformation as of 10/23/2026
Company Profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.